AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

RepliCel Life Sciences Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0.04
Year Range
$0$0.04
Market Cap
7.36K
AVG Volume
28
Trailing/Forward PE
-9.38/-
PEG ratio
0.05
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD)
0100K200K300K400K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Revenue (CAD) by quarter
PeriodRevenue (CAD)
26 Q288.47K
26 Q188.66K
25 Q4353.44K
25 Q30
25 Q20
25 Q161.45K
24 Q488.43K
24 Q388.43K
24 Q288.43K
24 Q188.43K
Net Income (CAD)
-10M-5M05M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Net Income (CAD) by quarter
PeriodNet Income (CAD)
26 Q2-71.6K
26 Q1-47.58K
25 Q47.87M
25 Q3-25.13K
25 Q2-28.65K
25 Q1-8.22M
24 Q4565.64K
24 Q3-216K
24 Q2-187.94K
24 Q1-251.83K
Operating Income (CAD)
-200K0200K400K600K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
26 Q254.89K
26 Q178.39K
25 Q4419.74K
25 Q3-7.57K
25 Q2-30.33K
25 Q1-144K
24 Q4-133K
24 Q3-79.65K
24 Q2-65.56K
24 Q1-126.23K
EBITDA (CAD)
-200K0200K400K600K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
26 Q254.89K
26 Q178.39K
25 Q4411.13K
25 Q3-7.57K
25 Q2-21.58K
25 Q1-143K
24 Q4-88.51K
24 Q3-79.52K
24 Q2-65.43K
24 Q1-126.1K
Cash Flows (CAD)
-300K-200K-100K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
26 Q2-44.83K
26 Q1-34.35K
25 Q4-31.34K
25 Q3-25.09K
25 Q2-88.31K
25 Q1-151.33K
24 Q4-105.15K
24 Q3-53.11K
24 Q2-212.47K
24 Q1-160.13K
EPS (CAD)
-0.2-0.100.10.224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF EPS (CAD) by quarter
PeriodEPS (CAD)
26 Q2-0
26 Q1-0
25 Q40.11
25 Q30
25 Q2-0
25 Q1-0.12
24 Q40.01
24 Q3-0
24 Q2-0
24 Q1-0
Expenses (CAD)
-100K0100K200K300KR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Expenses (CAD) by quarter
PeriodExpenses (CAD)
26 Q233.58K
26 Q110.27K
25 Q4-65.81K
25 Q37.57K
25 Q230.33K
25 Q1143.51K
24 Q4221.85K
24 Q3168.09K
24 Q2109.22K
24 Q1214.53K
Cash & Debt (CAD)
0500K1M1.5MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
26 Q25.5K
26 Q1815
25 Q45.52K
25 Q36.16K
25 Q215.21K
25 Q110.47K
24 Q41.81K
24 Q310.46K
24 Q2148.95K
24 Q116.64K
Debt ratios
-5-2.502.5524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Debt ratios by quarter
PeriodDebt ratios
26 Q22.08
26 Q12.31
25 Q44.25
25 Q3-3.77
25 Q2-2.83
25 Q1-2.25
24 Q4-1.89
24 Q3-2.27
24 Q2-0.83
24 Q1-0.55
Margins
0%25%50%75%100%23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q426 Q126 Q2
REPCF Margins by quarter
PeriodMargins
26 Q299.96%
26 Q199.74%
25 Q40%
25 Q10%
24 Q4100%
24 Q3100%
24 Q299.85%
24 Q199.85%
23 Q499.69%
23 Q3100%
Return on Capital
-250%0%250%500%750%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Return on Capital by quarter
PeriodReturn on Capital
26 Q21.42%
26 Q10.96%
25 Q4-160.38%
25 Q32.08%
25 Q22.43%
25 Q1713.14%
24 Q4-12.54%
24 Q34.16%
24 Q23.78%
24 Q15.27%
Shares Outstanding
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Shares Outstanding by quarter
PeriodShares Outstanding
26 Q270M
26 Q170M
25 Q470.01M
25 Q373.58M
25 Q270M
25 Q170M
24 Q464.71M
24 Q361.44M
24 Q261.44M
24 Q161.43M
Book Value Per Share (CAD)
-0.1-0.08-0.05-0.03-024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
26 Q2-0.07
26 Q1-0.07
25 Q4-0.07
25 Q3-0.02
25 Q2-0.02
25 Q1-0.02
24 Q4-0.07
24 Q3-0.08
24 Q2-0.08
24 Q1-0.08
Total Assets (CAD)
0100K200K300K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
REPCF Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
26 Q280.91K
26 Q184.16K
25 Q497.01K
25 Q313.66K
25 Q222.32K
25 Q122.53K
24 Q4147.1K
24 Q3150.97K
24 Q2172.68K
24 Q1202.53K
Employee Count
024682013201420152016201720182019202020212022
REPCF Employee Count by quarter
PeriodEmployee Count
20222
20211
20202
20192
20182
20172
20162
20156
20147
20135
PE Ratio
02.557.510med 0.13Jul 24Sep 24Nov 24Dec 24Feb 25Jul 26Sep 26
REPCF PE Ratio by quarter
PeriodPE Ratio
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Mar 250.13
Mar 250.13
Mar 250.13
Mar 250.13
Feb 250.13
Feb 250.13
Feb 250.12
Feb 250.12
Jan 250.12
Jan 250.06
Jan 250.65
Jan 250.65
Jan 250.65
Dec 240.12
Dec 240.57
Dec 240.23
Dec 240.23
Nov 240.23
Nov 240.22
Nov 240.02
Nov 240.06
Nov 240.06
Oct 240.06
Oct 240.47
Oct 240.47
Oct 240.47
Sep 240.89
Sep 240.9
Sep 240.9
Sep 240.9
Aug 240.89
Aug 240.89
Aug 240.91
Aug 240.91
Aug 240.92
Jul 240.92
Jul 249.05
Jul 248.99
Jul 249
Free Cash Flow Yield
-40000%-30000%-20000%-10000%0%med -1820.21%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
REPCF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1844.72%
Sep 26-1849.69%
Aug 26-1840.41%
Aug 26-1858.89%
Aug 26-1844.24%
Aug 26-1835.86%
Jul 26-1825.91%
Jul 26-1815.53%
Jul 26-1824.89%
Jul 26-1808.01%
Jul 26-1804.13%
Jun 26-2981.02%
Jun 26-2991.74%
Jun 26-3023.69%
Jun 26-3034.54%
May 26-3067.66%
May 26-3061.47%
May 26-3077.13%
May 26-3092.95%
May 26-3113.17%
Apr 26-3095.01%
Apr 26-3089.69%
Apr 26-3056.16%
Apr 26-30388.34%
Mar 26-3619.24%
Mar 26-3664.54%
Mar 26-3664.06%
Mar 26-3707.57%
Feb 26-3686.25%
Feb 26-3676.66%
Feb 26-3692.75%
Feb 26-3677.54%
Jan 26-3692.21%
Jan 26-3670.37%
Jan 26-3613.18%
Jan 26-3614.06%
Jan 26-3662.14%
Dec 25-4157.87%
Dec 25-4120.11%
Dec 25-4128.04%
Dec 25-4114.68%
Nov 25-4068.76%
Nov 25-4032.22%
Nov 25-4054.8%
Nov 25-4047.15%
Oct 25-4059.66%
Oct 25-4062.19%
Oct 25-4055.15%
Oct 25-4061.29%
Oct 25-4076.38%
Sep 25-5350.67%
Sep 25-5415.36%
Sep 25-5387.19%
Sep 25-269.75%
Aug 25-271.43%
Aug 25-269.81%
Aug 25-269.94%
Aug 25-271.11%
Aug 25-270.47%
Jul 25-272.24%
Jul 25-271.82%
Jul 25-272.49%
Jul 25-274.55%
Jun 25-299.9%
Jun 25-298.71%
Jun 25-302.09%
Jun 25-299.66%
May 25-298.64%
May 25-298.81%
May 25-293.72%
May 25-294.46%
May 25-296.98%
Apr 25-296.21%
Apr 25-296.54%
Apr 25-295.89%
Apr 25-288.34%
Mar 25-50.16%
Mar 25-50.03%
Mar 25-49.96%
Mar 25-49.99%
Feb 25-49.65%
Feb 25-50.5%
Feb 25-53.29%
Feb 25-52.9%
Jan 25-52.03%
Jan 25-100.13%
Jan 25-9.92%
Jan 25-9.96%
Jan 25-9.94%
Dec 24-265.9%
Dec 24-53.33%
Dec 24-134.65%
Dec 24-135.38%
Nov 24-130.33%
Nov 24-137.12%
Nov 24-1295.5%
Nov 24-475.13%
Nov 24-473.74%
Oct 24-475.65%
Oct 24-64.82%
Price to Sales
0123med 0.07Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
REPCF Price to Sales by quarter
PeriodPrice to Sales
Sep 260.02
Sep 260.02
Aug 260.02
Aug 260.02
Aug 260.02
Aug 260.02
Jul 260.02
Jul 260.02
Jul 260.02
Jul 260.02
Jul 260.02
Jun 260.02
Jun 260.02
Jun 260.02
Jun 260.02
May 260.02
May 260.02
May 260.02
May 260.02
May 260.02
Apr 260.02
Apr 260.02
Apr 260.02
Apr 260
Mar 260.07
Mar 260.07
Mar 260.07
Mar 260.07
Feb 260.07
Feb 260.07
Feb 260.07
Feb 260.07
Jan 260.07
Jan 260.07
Jan 260.07
Jan 260.07
Jan 260.07
Dec 250.04
Dec 250.04
Dec 250.04
Dec 250.04
Nov 250.04
Nov 250.04
Nov 250.04
Nov 250.04
Oct 250.04
Oct 250.04
Oct 250.04
Oct 250.04
Oct 250.04
Sep 250.03
Sep 250.03
Sep 250.03
Sep 250.59
Aug 250.59
Aug 250.59
Aug 250.59
Aug 250.59
Aug 250.59
Jul 250.59
Jul 250.59
Jul 250.59
Jul 250.58
Jun 250.5
Jun 250.5
Jun 250.5
Jun 250.5
May 250.5
May 250.5
May 250.51
May 250.51
May 250.51
Apr 250.51
Apr 250.51
Apr 250.51
Apr 250.52
Mar 250.5
Mar 250.5
Mar 250.5
Mar 250.5
Feb 250.5
Feb 250.49
Feb 250.47
Feb 250.47
Jan 250.48
Jan 250.25
Jan 252.51
Jan 252.5
Jan 252.51
Dec 240.25
Dec 241.25
Dec 240.49
Dec 240.49
Nov 240.51
Nov 240.49
Nov 240.05
Nov 240.14
Nov 240.14
Oct 240.14
Oct 241.03
EV/EBITDA
22.533.544.5med 4.27Apr 26May 26Jun 26Jul 26Aug 26Sep 26
REPCF EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 262.33
Sep 262.33
Aug 262.33
Aug 262.33
Aug 262.33
Aug 262.33
Jul 262.33
Jul 262.33
Jul 262.33
Jul 262.33
Jul 262.33
Jun 264.29
Jun 264.29
Jun 264.29
Jun 264.29
May 264.29
May 264.29
May 264.29
May 264.29
May 264.29
Apr 264.29
Apr 264.29
Apr 264.29
Apr 264.26
RepliCel Life Sciences Inc.
REPCF
Stockpicker

Video analysis: REPCF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.